Ambeed.cn

首页 / / / 端粒酶 / MST-312

MST-312 {[allProObj[0].p_purity_real_show]}

货号:A207531 同义名: Telomerase Inhibitor IX

MST-312是一种合成化合物,作为可逆的端粒酶(TERT)抑制剂,比表没食子酸没食子酯更具效力。

HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
MST-312 化学结构 CAS号:368449-04-1
MST-312 化学结构
CAS号:368449-04-1
MST-312 3D分子结构
CAS号:368449-04-1
MST-312 化学结构 CAS号:368449-04-1
MST-312 3D分子结构 CAS号:368449-04-1
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

MST-312 纯度/质量文件 产品仅供科研

货号:A207531 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 Telomerase 其他靶点 纯度
4',7-Dimethoxyisoflavone 97%
BIBR 1532 +++

Telomerase, IC50: 100 nM

99%+
Costunolide ++

Telomerase (MCF-7), IC50: 90 μM

Telomerase (MDA-MB-231), IC50: 65 μM

98%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

MST-312 生物活性

描述 MST-312, also called Telomerase inhibitor IX, is a synthetic compound that acts as a reversible TERT (telomerase) inhibitor, and is described to be more potent than epigallocatechin gallate.

MST-312 细胞实验

Cell Line
Concentration Treated Time Description References
HT-29 10 µM 24 hours Inhibited telomerase activity, reduced CD133 (+) subpopulation Int J Oncol. 2016 Aug;49(2):487-98
MDA-MB-231 10 µM 24 hours Reduced CD44 (+) subpopulation, inhibited wound healing capacity Int J Oncol. 2016 Aug;49(2):487-98
SW620 10 µM 24 hours Inhibited telomerase activity, reduced CD133 (+) subpopulation Int J Oncol. 2016 Aug;49(2):487-98
KNS60 cells 1.0 μM 48 hours Assessed the inhibitory effect of MST-312 on telomerase activity, showing inhibition. Mol Cancer. 2014 Oct 13;13:232
MO59K cells 1.0 μM 48 hours Assessed the inhibitory effect of MST-312 on telomerase activity, showing reversible inhibition. Mol Cancer. 2014 Oct 13;13:232
ONS76 cells 1.0 μM 48 hours Assessed the inhibitory effect of MST-312 on telomerase activity, showing dose-dependent inhibition. Mol Cancer. 2014 Oct 13;13:232
OSE (Human Ovarian Surface Epithelial cells) 0.01–50 µM 72 hours MST-312 had an IC50 of 8 µM in OSE cells and showed cytoprotective effects at low concentrations. Transl Oncol. 2023 Jan;27:101569
HCT116 (colorectal carcinoma) 0.01–50 µM 72 hours MST-312 induced cytotoxicity in a dose-dependent manner with IC50 of 5.9 µM. Transl Oncol. 2023 Jan;27:101569
A2780cisR (ovarian adenocarcinoma cisplatin-resistant cell line) 0.01–50 µM 72 hours MST-312 induced cytotoxicity in a dose-dependent manner with IC50 of 3.6 µM. Transl Oncol. 2023 Jan;27:101569
OVCAR3 (ovarian adenocarcinoma cell line) 0.01–50 µM 72 hours MST-312 induced cytotoxicity in a dose-dependent manner with IC50 of 7.1 µM. Transl Oncol. 2023 Jan;27:101569
A2780 (ovarian adenocarcinoma cell line) 0.01–50 µM 72 hours MST-312 induced cytotoxicity in a dose-dependent manner with IC50 of 3.9 µM. Transl Oncol. 2023 Jan;27:101569
PA-1 (ovarian teratocarcinoma cell line) 0.01–50 µM 72 hours MST-312 induced cytotoxicity in a dose-dependent manner with IC50 of 4.2 µM. Transl Oncol. 2023 Jan;27:101569
H1299 cells 0.25 μM 120 hours MST312 significantly inhibited H1299 cell proliferation, with ALDH+ cells being more sensitive than ALDH- cells. Mol Cancer. 2011 Aug 9;10:96
H460 cells 1 μM 120 hours MST312 exhibited a dose-dependent antiproliferative effect on H460 cells, with ALDH+ cells being more sensitive than ALDH- cells. Mol Cancer. 2011 Aug 9;10:96
MDA-MB-435 0.23 μM (IC50) 24 hours To investigate the inhibitory effect of MST-312 on telomerase activity and its impact on cancer cell survival. Results showed that MST-312 inhibited telomerase activity in a concentration-dependent manner with an IC50 of 0.23 μM. Eur J Med Chem. 2017 Jan 5;125:117-129
primary ependymoma cells 0 to 4 μM 72 hours To evaluate the effect of MST-312 on cell viability. Results showed a significant decrease in cell number (P<0.001), increased DNA damage (γH2AX expression, P<0.01), decreased proliferative index (MIB-1, P<0.01), and increased apoptosis in some cells (cleaved caspase 3). Brain Pathol. 2010 Jul;20(4):780-6
NCI-H441 cells 2.5 μM 28 days Induced cellular senescence and increased secretion of pro-inflammatory cytokines Respir Res. 2011 Jun 10;12(1):78
Leishmania major promastigote cells 0.1 to 4 µM 30 minutes To test the effect of human telomerase inhibitors on L. major telomerase activity. Both MST-312 and TMPyP4 effectively inhibited L. major telomerase activity, with MST-312 being more potent, achieving complete inhibition at 0.5µM, which is eight times lower than the concentration required for TMPyP4. Microorganisms. 2025 Feb 7;13(2):357
FLO-1 cells 1 μM 10 days To evaluate the antiproliferative effect of MST-312 analog GRN163L on H460 cells, results showed that SFN enhanced the activity of GRN163L. Transl Oncol. 2010 Dec 1;3(6):389-99
HEp-2 cells 20-100 μM 18 hours MST-312 inhibits HSV-1 replication, reduces viral protein accumulation. J Virol. 2015 Oct;89(19):9804-16
hTERT-HME1 cells 20-100 μM 18 hours MST-312 inhibits HSV-1 replication, reduces cytopathic effects and viral protein accumulation. J Virol. 2015 Oct;89(19):9804-16

MST-312 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Athymic mice H460 xenograft model Intraperitoneal injection 40 mg/kg Once daily for 25 days MST312 significantly reduced tumor volume (70% reduction), decreased the number of ALDH+ CSCs, and induced apoptosis. Mol Cancer. 2011 Aug 9;10:96

MST-312 参考文献

[1]Morais KS, Guimaraesb AFR, et al. Long-term exposure to MST-312 leads to telomerase reverse transcriptase overexpression in MCF-7 breast cancer cells. Anticancer Drugs. 2017 May 17.

[2]Chung SS, Oliva B, et al. Combination treatment with flavonoid morin and telomerase inhibitor MST‑312 reduces cancer stem cell traits by targeting STAT3 and telomerase. Int J Oncol. 2016 Aug;49(2):487-98.

MST-312 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.63mL

0.53mL

0.26mL

13.15mL

2.63mL

1.31mL

26.29mL

5.26mL

2.63mL

MST-312 技术信息

CAS号368449-04-1
分子式C20H16N2O6
分子量 380.35
SMILES Code O=C(NC1=CC=CC(NC(C2=CC=CC(O)=C2O)=O)=C1)C3=CC=CC(O)=C3O
MDL No. MFCD24368986
别名 Telomerase Inhibitor IX
运输蓝冰
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Sealed in dry, 2-8°C

溶解方案

DMSO: 120 mg/mL(315.5 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。